CN1250521C - 乙酰基l－肉碱酸式富马酸盐及其制备方法 - Google Patents

乙酰基l－肉碱酸式富马酸盐及其制备方法 Download PDF

Info

Publication number
CN1250521C
CN1250521C CNB028248260A CN02824826A CN1250521C CN 1250521 C CN1250521 C CN 1250521C CN B028248260 A CNB028248260 A CN B028248260A CN 02824826 A CN02824826 A CN 02824826A CN 1250521 C CN1250521 C CN 1250521C
Authority
CN
China
Prior art keywords
acetyl
carnitine
acid fumarate
solution
fumarate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB028248260A
Other languages
English (en)
Chinese (zh)
Other versions
CN1602294A (zh
Inventor
A·法西
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Publication of CN1602294A publication Critical patent/CN1602294A/zh
Application granted granted Critical
Publication of CN1250521C publication Critical patent/CN1250521C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/08—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to hydrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/02—Preparation of carboxylic acid esters by interreacting ester groups, i.e. transesterification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
CNB028248260A 2001-12-12 2002-11-25 乙酰基l－肉碱酸式富马酸盐及其制备方法 Expired - Fee Related CN1250521C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITRM2001A000729 2001-12-12
IT2001RM000729A ITRM20010729A1 (it) 2001-12-12 2001-12-12 Sale di acetil l-carnitina con un acido organico dicarbossilico e procedimento per la sua preparazione.

Publications (2)

Publication Number Publication Date
CN1602294A CN1602294A (zh) 2005-03-30
CN1250521C true CN1250521C (zh) 2006-04-12

Family

ID=11455916

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB028248260A Expired - Fee Related CN1250521C (zh) 2001-12-12 2002-11-25 乙酰基l－肉碱酸式富马酸盐及其制备方法

Country Status (18)

Country Link
US (1) US6673837B2 (https=)
EP (1) EP1453791B1 (https=)
JP (1) JP4902940B2 (https=)
KR (1) KR100860386B1 (https=)
CN (1) CN1250521C (https=)
AT (1) ATE457300T1 (https=)
AU (1) AU2002358989A1 (https=)
CA (1) CA2468234C (https=)
CY (1) CY1110684T1 (https=)
DE (1) DE60235318D1 (https=)
DK (1) DK1453791T3 (https=)
ES (1) ES2339432T3 (https=)
HU (1) HU230034B1 (https=)
IT (1) ITRM20010729A1 (https=)
PL (1) PL207877B1 (https=)
PT (1) PT1453791E (https=)
SI (1) SI1453791T1 (https=)
WO (1) WO2003053911A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8173618B2 (en) * 2003-07-25 2012-05-08 University Of Massachusetts Formulations for reducing neuronal degeneration
CN101209975B (zh) * 2006-12-29 2010-12-01 沈阳科硕营养科技有限公司 左旋肉碱富马酸钙及其制备方法与用途
US8597640B2 (en) * 2007-10-31 2013-12-03 University Of Massachusetts Lowell Over-the-counter vitamin/nutriceutical formulation that provides neuroprotection and maintains or improves cognitive performance in alzheimer's disease and normal aging
JP2012092036A (ja) * 2010-10-26 2012-05-17 Mitsubishi Rayon Co Ltd カルニチンの塩の製造方法
BR112014003459A2 (pt) * 2011-08-31 2017-03-01 Procter & Gamble elemento de fixação tendo camada de reforço ligada
JP5933383B2 (ja) * 2012-07-26 2016-06-08 ロート製薬株式会社 内服用固形製剤の吸湿性・流動性の改善方法、吸湿性・流動性が改善されてなる内服用固形製剤、及び該内服用固形製剤の製造法
JP6100939B2 (ja) * 2016-02-26 2017-03-22 ロート製薬株式会社 内服用固形製剤の吸湿性・流動性の改善方法、吸湿性・流動性が改善されてなる内服用固形製剤、及び該内服用固形製剤の製造法
JP6964876B2 (ja) * 2017-11-27 2021-11-10 株式会社古川リサーチオフィス オロット酸−カルニチン混合体粉体又はフマル酸−カルニチン混合体粉体の製造方法
CN119351483B (zh) * 2024-12-03 2025-05-30 北京佰依源生物科技有限公司 一种长碳链二元酸生产强度提高的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3463261D1 (en) * 1983-12-28 1987-05-27 Sigma Tau Ind Farmaceuti Salts of l-carnitine and alkanoyl l-carnitines and process for preparing same

Also Published As

Publication number Publication date
KR20040064721A (ko) 2004-07-19
EP1453791B1 (en) 2010-02-10
SI1453791T1 (sl) 2010-11-30
JP4902940B2 (ja) 2012-03-21
ATE457300T1 (de) 2010-02-15
HUP0402545A3 (en) 2012-09-28
CN1602294A (zh) 2005-03-30
JP2005513122A (ja) 2005-05-12
EP1453791A1 (en) 2004-09-08
CA2468234A1 (en) 2003-07-03
PL371130A1 (en) 2005-06-13
WO2003053911A1 (en) 2003-07-03
CY1110684T1 (el) 2015-06-10
CA2468234C (en) 2010-02-23
PL207877B1 (pl) 2011-02-28
ES2339432T3 (es) 2010-05-20
HUP0402545A2 (hu) 2005-04-28
KR100860386B1 (ko) 2008-09-26
AU2002358989A1 (en) 2003-07-09
US20030119904A1 (en) 2003-06-26
DK1453791T3 (da) 2010-05-25
HU230034B1 (hu) 2015-05-28
HK1073295A1 (en) 2005-09-30
DE60235318D1 (de) 2010-03-25
ITRM20010729A1 (it) 2003-06-12
PT1453791E (pt) 2010-04-14
US6673837B2 (en) 2004-01-06

Similar Documents

Publication Publication Date Title
EP2857386B1 (en) Tigecycline crystalline forms and processes for preparation thereof
JP4559431B2 (ja) 固体及び結晶イバンドロネートナトリウム及びその調製方法
US20120029083A1 (en) Polymorphic forms of aliskiren hemifumarate and process for preparation thereof
CN1250521C (zh) 乙酰基l－肉碱酸式富马酸盐及其制备方法
CN1602304A (zh) 氘代的取代的二氢呋喃酮以及包含该化合物的药物组合物
CN1898211A (zh) 喹啉化合物的晶形及其生产方法
US9150982B2 (en) Crystal form of (6S)-5-methyltetrahydrofolate salt and method for preparing same
US20100035994A1 (en) Novel hydrate form of o-desmethyl venlafaxine succinate
US7417165B2 (en) Crystalline forms of pregabalin
US20070093458A1 (en) Preparation of paricalcitol and crystalline forms thereof
HK1073295B (en) Acetyl l-carnitine acid fumarate and process for preparing the same
CN1902166A (zh) 高化学纯度r－5－(2－(2－(2－乙氧基苯氧基乙基氨基)丙基)－2－甲氧基苯磺酰胺盐酸盐的制备
CN1245389C (zh) 芳基乙烯磺酰胺衍生物的新型结晶及其制造方法
CN1293039C (zh) [(S)－(－)－α－甲胺基苯丙酮]2·(2R,3R)－酒石酸衍生物的制备方法
CN1880294A (zh) 右酮洛芬氨丁三醇的多晶型、其制备方法和包含它的组合物
US6998503B2 (en) Crystalline solid form of (2S,5Z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid
JPS6072848A (ja) Ｌまたは（ｓ）−３−（３．４−ジヒドロキシフエニル）−２−メチルアラニンエステルの結晶性塩およびその製法
HK1073108A (en) Deuterated substituted dihydrofuranones and medicaments containing these compounds
HK1083741B (en) Pharmaceutical composition comprising crystalline sibutramine methanesulfonate hemihydrate

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1073295

Country of ref document: HK

C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20060412

Termination date: 20151125